The pharmaceutical manufacturing software market has seen considerable growth due to a variety of factors.
• The rapid expansion of the pharmaceutical manufacturing software market has been noticeable in recent years. The market is projected to expand from $3.3 billion in 2024 to $3.82 billion in 2025, with a compound annual growth rate (CAGR) of 16.0%.
The past growth is due to factors such as regulatory compliance mandates, increasing intricacy in drug production, the need for better quality control, increased production in biopharmaceuticals, along with the demand for increased efficiency and cost reduction.
The pharmaceutical manufacturing software market is expected to maintain its strong growth trajectory in upcoming years.
• In the upcoming years, a swift expansion is projected for the market of pharmaceutical manufacturing software. The market is poised to reach $6.83 billion by 2029, with a compound annual growth rate (CAGR) of 15.6%.
The anticipated growth during this period is driven by factors such as the emergence of personalized medicine, increased R&D investments, greater emphasis on optimizing supply chains, an expanding biopharmaceutical sector, and escalating worldwide health issues. Noticeable trends for the period of forecast consist of the adoption of AI, the integration of cloud-based solutions and IoT technologies, real-time monitoring, and sophisticated quality management practices.
The growth of the pharmaceutical manufacturing software market is likely to be driven by the surge in drug production. This process, which involves an established procedure of formulating, testing, and packaging pharmaceutical goods, is pivotal to ensuring quality, safety, and efficacy. The expanding global need for drugs, emerging public health hurdles, and the urgency to make treatments available for a myriad of health conditions necessitate more drug production. This is where pharmaceutical manufacturing software plays a key role, by consolidating processes, enhancing data precision, making optimum use of resources, and maintaining adherence to regulations. In doing so, it significantly increases efficiency and expandability. A case in point is the statistics from the European Federation of Pharmaceutical Industries and Associations (EFPIA). This Belgium-located entity that speaks for the pharmaceutical sector reported a significant expansion in the European pharmaceutical industry's production. The production skyrocketed from $352.48 billion in 2021 to $369.95 billion in 2022, as per the June 2023 data. Hence, the rise in drug production will stimulate the growth of the pharmaceutical manufacturing software market.
The pharmaceutical manufacturing softwaremarket covered in this report is segmented –
1) By Software Type: Manufacturing Execution Systems (MES), Enterprise Resource Planning (ERP) Systems, Laboratory Information Management Systems (LIMS), Quality Management Systems (QMS), Process Analytical Technology (PAT) Systems, Regulatory Compliance Software
2) By Deployment Mode: On-Premises, Cloud-Based
3) By Application: Large Enterprise, Small And Midsize Enterprise
4) By End-User: Biopharmaceutical Companies, Medical Device Companies, Contract Research Organizations, Academic Research Institutions, Other End Users
Subsegments:
1) Manufacturing Execution Systems (MES): Production Tracking Software, Resource Management Tools, Real-Time Monitoring Solutions
2) Enterprise Resource Planning (ERP) Systems: Financial Management Software, Supply Chain Management Software, Inventory Management Solutions
3) Laboratory Information Management Systems (LIMS): Sample Management Software, Data Analysis Tools, Workflow Automation Systems
4) Quality Management Systems (QMS): Document Control Software, CAPA Management Tools, Audit Management Solutions
5) Process Analytical Technology (PAT) Systems: Inline Analysis Tools, Process Control Software, Data Acquisition Systems
6) Regulatory Compliance Software: Validation Management Solutions, Compliance Tracking Software, Risk Management Tools
Several leading businesses in the pharmaceutical manufacturing software sector are prioritizing process enhancement by combining smart manufacturing technologies, such as AI-based tools, to strengthen predictive analytics, streamline the manufacturing processes, and boost overall operational efficacy. AI-based tools in pharmaceutical manufacturing software utilize artificial intelligence to refine procedures, amplify quality control, and heighten decision-making across medicine production. An exemplification of this is the launch of Connect CMC, an AI-enabled tool that is aimed to transform data management for small pharmaceutical and biotech businesses, by Mareana, a US-based firm specializing in AI-powered analytics and supply chain solutions for the pharmaceutical and life sciences trade, in February 2024. Connect CMC maximizes efficiency, precision, and cost-effective benefits by automating data extraction from paper batch documents and ensuring GxP compliance, thereby propelling digital transition in drug invention.
Major companies operating in the pharmaceutical manufacturing software market are:
• McKesson Corporation
• Oracle Corporation
• SAP SE
• ABB Ltd.
• Rockwell Automation Inc.
• Dassault Systèmes SE
• NetSuite Inc.
• The Sage Group plc
• Epicor Software Corporation
• QAD Inc.
• Intellect Design Arena Ltd.
• Columbus Manufacturing Inc.
• MasterControl Inc.
• Sapphire Systems Ltd.
• DESKERA PTE LTD
• Vormittag Associates Inc.
• Logic ERP Solutions Pvt Ltd.
• SYSPRO (Pty) Ltd.
• Datacor Inc.
• BatchMaster Software Inc.
• Fishbowl Inc.
• Aquilon Software Inc.
• CompuTec S.A.
• ERPAG Inc.
• MRPeasy Ltd.
North America was the largest region in the pharmaceutical manufacturing software market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical manufacturing software market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.